Sunshine Act Meeting, 24327 [E8-9644]

Download as PDF Federal Register / Vol. 73, No. 86 / Friday, May 2, 2008 / Notices 11. The Commission shall have issued an order approving the Substitution under Section 26(c) of the 1940 Act. 12. A registration statement for the Substitute Fund is effective and the investment objectives and policies and fees and expenses for the Substitute Fund as described herein have been implemented. 13. Each Affected Contract Owner will have been sent a copy of (a) a Contract prospectus supplement informing shareholders of this Application; (b) a prospectus for the Substitute Fund, and (c) a second supplement to the Contract prospectus setting forth the Effective Date and advising Affected Contract Owners of their right to reconsider the Substitution and, if they so choose, any time prior to the Effective Date and for 30 days thereafter, to reallocate or withdraw amounts under their affected Contract or otherwise terminate their interest therein in accordance with the terms and conditions of their Contract. 14. The Companies shall have satisfied themselves, that (a) the Contracts allow the substitution of investment company shares in the manner contemplated by the Substitution and related transactions described herein; (b) the transaction can be consummated as described in this Application under applicable insurance laws; and (c) that any regulatory requirements in each jurisdiction where the Contracts are qualified for sale, have been complied with to the extent necessary to complete the transaction. Conclusion For the reasons and upon the facts set forth above, Applicants submit that the requested order meets the standards set forth in Section 26(c) of the 1940 Act. Applicants request an order of the Commission, pursuant to Section 26(c) of the 1940 Act, approving the Substitutions. For the Commission, by the Division of Investment Management, pursuant to delegated authority. Florence E. Harmon, Deputy Secretary. [FR Doc. E8–9632 Filed 5–1–08; 8:45 am] BILLING CODE 8010–01–P mstockstill on PROD1PC66 with NOTICES SECURITIES AND EXCHANGE COMMISSION Sunshine Act Meeting Notice is hereby given, pursuant to the provisions of the Government in the Sunshine Act, Pub. L. 94–409, that the Securities and Exchange Commission will hold an Open Meeting on Monday, VerDate Aug<31>2005 17:17 May 01, 2008 Jkt 214001 May 5, 2008 at 10 a.m., in the Auditorium, Room L–002. The subject matter of the Open Meeting will be: 1. The Commission will hear oral argument on an appeal by Impax Laboratories, Inc. from an initial decision of an administrative law judge. Impax, a Delaware corporation, develops, manufactures, and distributes pharmaceutical products. Impax’s common stock is registered with the Commission pursuant to Section 12(g) of the Securities Exchange Act of 1934. The law judge found that Impax had violated Exchange Act Section 13(a) and Exchange Act Rules 13a–1 and 13a–13 thereunder by failing to file its required quarterly and annual reports for any period after September 30, 2004. The law judge revoked the registration of Impax’s common stock. Impax does not appeal the law judge’s findings of violation. However, Impax does appeal the sanction imposed by the law judge. Issues likely to be considered include whether the protection of investors requires revoking the Section 12(g) registration of Impax’s common stock. 2. The Commission will also hear oral argument on an appeal by Robert Radano from an initial decision of an administrative law judge barring him from associating with any investment adviser. The law judge based his decision to impose a bar on Radano’s having been enjoined from future violations of (A) Sections 206(1) and (2)—the antifraud provisions—of the Investment Advisers Act, and (B) Investment Advisers Act Section 203(f), which prohibits investment advisers from associating with a barred individual. Issues likely to be considered include whether it is in the public interest to bar Radano from association with any investment adviser. At times, changes in Commission priorities require alterations in the scheduling of meeting items. For further information and to ascertain what, if any, matters have been added, deleted or postponed, please contact: The Office of the Secretary at (202) 551–5400. Dated: April 28, 2008. Florence E. Harmon, Deputy Secretary. [FR Doc. E8–9644 Filed 5–1–08; 8:45 am] BILLING CODE 8010–01–P PO 00000 Frm 00117 Fmt 4703 Sfmt 4703 24327 SECURITIES AND EXCHANGE COMMISSION [Release No. 34–57713; File No. SR–BSE– 2008–28] Self-Regulatory Organizations; Boston Stock Exchange, Inc.; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Regarding Transfer of BOX Units From the ´ Montreal Exchange Inc. to MX US 2, Inc. April 25, 2008. Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’),1 and Rule 19b–4 thereunder,2 notice is hereby given that on April 22, 2008, the Boston Stock Exchange, Inc. (‘‘BSE’’ or ‘‘Exchange’’) filed with the Securities and Exchange Commission (‘‘Commission’’) the proposed rule change as described in Items I and II below which Items have been substantially prepared by the BSE. The Exchange filed the proposal as a ‘‘noncontroversial’’ proposed rule change pursuant to Section 19(b)(3)(A) of the Act 3 and Rule 19b–4(f)(6) thereunder,4 which renders the proposal effective upon filing with the Commission. The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons. I. Self-Regulatory Organization’s Statement of the Terms of Substance of the Proposed Rule Change The Exchange is submitting the proposed rule change to the Commission to amend the Fifth Amended and Restated Operating Agreement, dated January 26, 2005, (‘‘BOX LLC Agreement’’), of the Boston Options Exchange Group LLC (‘‘BOX LLC’’), in connection with the transfer ´ by the Montreal Exchange Inc.,5 a ´ company incorporated in Quebec, Canada (‘‘MX’’), of its 31.37% ownership interest in BOX LLC to MX U.S. 2, Inc. (‘‘MX US’’), a wholly-owned U.S. subsidiary of MX.6 The text of the proposed rule change is available at the BSE, the Commission’s Public Reference Room, and https://www.bostonstock.com. 1 15 U.S.C. 78s(b)(1). CFR 240.19b–4. 3 15 U.S.C. 78s(b)(3)(A). 4 17 CFR 240.19b–4(f)(6). 5 The Montreal Exchange Inc. is also known in ´ ´ French as the Bourse de Montreal Inc. 6 Capitalized terms not otherwise defined herein shall have the meanings set forth in the BOX LLC Agreement. 2 17 E:\FR\FM\02MYN1.SGM 02MYN1

Agencies

[Federal Register Volume 73, Number 86 (Friday, May 2, 2008)]
[Notices]
[Page 24327]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-9644]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Sunshine Act Meeting

    Notice is hereby given, pursuant to the provisions of the 
Government in the Sunshine Act, Pub. L. 94-409, that the Securities and 
Exchange Commission will hold an Open Meeting on Monday, May 5, 2008 at 
10 a.m., in the Auditorium, Room L-002.
    The subject matter of the Open Meeting will be:
    1. The Commission will hear oral argument on an appeal by Impax 
Laboratories, Inc. from an initial decision of an administrative law 
judge. Impax, a Delaware corporation, develops, manufactures, and 
distributes pharmaceutical products. Impax's common stock is registered 
with the Commission pursuant to Section 12(g) of the Securities 
Exchange Act of 1934.
    The law judge found that Impax had violated Exchange Act Section 
13(a) and Exchange Act Rules 13a-1 and 13a-13 thereunder by failing to 
file its required quarterly and annual reports for any period after 
September 30, 2004. The law judge revoked the registration of Impax's 
common stock.
    Impax does not appeal the law judge's findings of violation. 
However, Impax does appeal the sanction imposed by the law judge.
    Issues likely to be considered include whether the protection of 
investors requires revoking the Section 12(g) registration of Impax's 
common stock.
    2. The Commission will also hear oral argument on an appeal by 
Robert Radano from an initial decision of an administrative law judge 
barring him from associating with any investment adviser. The law judge 
based his decision to impose a bar on Radano's having been enjoined 
from future violations of (A) Sections 206(1) and (2)--the antifraud 
provisions--of the Investment Advisers Act, and (B) Investment Advisers 
Act Section 203(f), which prohibits investment advisers from 
associating with a barred individual. Issues likely to be considered 
include whether it is in the public interest to bar Radano from 
association with any investment adviser.
    At times, changes in Commission priorities require alterations in 
the scheduling of meeting items.
    For further information and to ascertain what, if any, matters have 
been added, deleted or postponed, please contact:
    The Office of the Secretary at (202) 551-5400.

    Dated: April 28, 2008.
Florence E. Harmon,
Deputy Secretary.
 [FR Doc. E8-9644 Filed 5-1-08; 8:45 am]
BILLING CODE 8010-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.